Package 25021-100-10

Brand: cefazolin

Generic: cefazolin sodium
NDC Package

Package Facts

Identity

Package NDC 25021-100-10
Digits Only 2502110010
Product NDC 25021-100
Product ID 25021-100_158968cf-18f0-4590-b2ac-2e654802686c
Description

25 VIAL in 1 CARTON (25021-100-10) / 2.2 mL in 1 VIAL

Marketing

Marketing Status
Discontinued 2026-02-28
Brand cefazolin
Generic cefazolin sodium
Sample Package No

Linked Drug Pages (1)

cefazolin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "158968cf-18f0-4590-b2ac-2e654802686c", "openfda": {"unii": ["P380M0454Z"], "rxcui": ["1665050", "1665052"], "spl_set_id": ["e8f40f72-3cf0-43dc-a797-fb98dd8af228"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-100-10)  / 2.2 mL in 1 VIAL", "package_ndc": "25021-100-10", "marketing_end_date": "20260228", "marketing_start_date": "20090201"}], "brand_name": "cefazolin", "product_id": "25021-100_158968cf-18f0-4590-b2ac-2e654802686c", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "25021-100", "generic_name": "cefazolin sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cefazolin", "active_ingredients": [{"name": "CEFAZOLIN SODIUM", "strength": "500 mg/2.2mL"}], "application_number": "ANDA065303", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20090201"}